Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Silvercrest Ast Cm A (SAMG)

Silvercrest Ast Cm A (SAMG)
8.38 x 2 24.00 x 2
Post-market by (Cboe BZX)
15.03 -0.06 (-0.40%) 04/25/25 [NASDAQ]
8.38 x 2 24.00 x 2
Post-market 15.03 unch (unch) 16:02 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
14.79
Day High
15.22
Open 14.96
Previous Close 15.09 15.09
Volume 37,600 37,600
Avg Vol 70,445 70,445
Stochastic %K 42.61% 42.61%
Weighted Alpha -7.59 -7.59
5-Day Change +0.25 (+1.69%) +0.25 (+1.69%)
52-Week Range 14.15 - 19.20 14.15 - 19.20
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 205,737
  • Shares Outstanding, K 13,634
  • Annual Sales, $ 123,650 K
  • Annual Income, $ 9,540 K
  • EBIT $ 18 M
  • EBITDA $ 22 M
  • 60-Month Beta 0.80
  • Price/Sales 1.65
  • Price/Cash Flow 10.35
  • Price/Book 1.72

Options Overview Details

View History
  • Implied Volatility 97.03% ( -3.24%)
  • Historical Volatility 28.49%
  • IV Percentile 95%
  • IV Rank 96.00%
  • IV High 100.27% on 04/21/25
  • IV Low 19.34% on 07/11/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 3
  • Put/Call OI Ratio 1.00
  • Today's Open Interest 8
  • Open Int (30-Day) 10

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.36
  • Number of Estimates 1
  • High Estimate 0.36
  • Low Estimate 0.36
  • Prior Year 0.33
  • Growth Rate Est. (year over year) +9.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.26 +5.38%
on 04/09/25
Period Open: 16.10
16.68 -9.89%
on 03/27/25
-1.07 (-6.65%)
since 03/25/25
3-Month
14.26 +5.38%
on 04/09/25
Period Open: 18.12
19.03 -21.04%
on 02/19/25
-3.09 (-17.05%)
since 01/24/25
52-Week
14.15 +6.22%
on 05/03/24
Period Open: 14.84
19.20 -21.72%
on 12/16/24
+0.19 (+1.28%)
since 04/25/24

Most Recent Stories

More News
Silvercrest Asset Management Group Appoints J. Allen Gray to Board of Directors

SAMG : 15.03 (-0.40%)
Silvercrest: Q4 Earnings Snapshot

Silvercrest: Q4 Earnings Snapshot

SAMG : 15.03 (-0.40%)
Silvercrest Asset Management Group Inc. Reports Q4 and Year-End 2024 Results

SAMG : 15.03 (-0.40%)
Silvercrest Asset Management (SAMG) to Announce Fourth Quarter and Year-End 2024 Results and Host Investor Conference Call

SAMG : 15.03 (-0.40%)
Silvercrest Appoints J. Allen Gray as Head of Institutional Business

SAMG : 15.03 (-0.40%)
Silvercrest Asset Management Group Inc. Announces Quarterly Dividend

SAMG : 15.03 (-0.40%)
Silvercrest Asset Management Announces New Partners

SAMG : 15.03 (-0.40%)
Silvercrest Asset Management Launches Global Value Opportunity Equity Strategy with $1.3 Billion Seed Investment from CBUS

Silvercrest announces a $1.3 billion investment from CBUS to launch its Global Value Opportunity Equity Strategy.Quiver AI SummarySilvercrest Asset Management Group Inc. has announced a significant seed...

SAMG : 15.03 (-0.40%)
Silvercrest Asset Management Announces Initial Seed Investment With Australia's Construction and Building Unions Superannuation Fund

SAMG : 15.03 (-0.40%)
3 Small-Cap Stocks on the Rise With Over 4% Dividend Yields

Check out these three small cap stocks that not only pay over 4% dividend yields, but have also seen their share prices rise significantly in recent months.

DLX : 15.36 (-0.65%)
SBGI : 14.78 (+1.44%)
SAMG : 15.03 (-0.40%)
OptimizeRx Releases First Environmental, Social and Governance (ESG) Report

ROCHESTER, Mich., April 29, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology...

OPRX : 8.66 (+3.34%)
UPDATE – Surveyed Physicians Say Access Challenges Impact Their Care Plans for up to 33% of Patients

Physicians report that medication access impacts initial therapy choice for some patients and may require changes to preferred treatment plan ROCHESTER,...

OPRX : 8.66 (+3.34%)
1 in 3 Surveyed Physicians Say They Would Make a Different Treatment Choice If Medication Access Was Not a Factor

1 in 4 say they’ve had to change a treatment plan due to medication access issues, highlighting how access barriers can impact patient care ROCHESTER,...

OPRX : 8.66 (+3.34%)
How to Find New Stocks for Your Portfolio

I like to read articles by people who aren't just bullish -- they've bought shares.

OPRX : 8.66 (+3.34%)
SI : 1.2500 (+0.81%)
LC : 10.96 (+0.83%)
VIR : 6.12 (-2.70%)
NARI : 79.97 (+0.05%)
Financial Times Ranks OptimizeRx Amongst Americas’ Fastest-Growing Companies for the Third Consecutive Year

OptimizeRx grew 2021 revenue by 42% year-over-year, spotlighting the rapid growth from the convergence of technology and healthcare...

OPRX : 8.66 (+3.34%)
OptimizeRx Acquires EvinceMed, a Specialty Drug Prescription Initiation Platform

OptimizeRx expands reach of its point-of-care solutions to simplify the prescribing process of specialty medications for healthcare providers, and to...

OPRX : 8.66 (+3.34%)
OptimizeRx to Participate In-Person at 34th Annual ROTH Conference, March 13-15, 2022

ROCHESTER, Mich., March 07, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology...

OPRX : 8.66 (+3.34%)
OptimizeRx Corporation (OPRX) Q4 2021 Earnings Call Transcript

OPRX earnings call for the period ending December 31, 2021.

OPRX : 8.66 (+3.34%)
OptimizeRx Reports Fourth Quarter and Full Year 2021 Financial Results, Revenue Increased 42%, Demand from Large Pharma Gains Momentum

Fourth quarter revenue Up 24% to $20.3 million, gross profit margin of 61%Introduction of key performance indicators (KPIs) representing “land and expand”...

OPRX : 8.66 (+3.34%)
OptimizeRx’s Mike Rousselle Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars

ROCHESTER, Mich., Feb. 01, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology...

OPRX : 8.66 (+3.34%)
OptimizeRx Releases First Environmental, Social and Governance (ESG) Report

ROCHESTER, Mich., April 29, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology...

OPRX : 8.66 (+3.34%)
UPDATE – Surveyed Physicians Say Access Challenges Impact Their Care Plans for up to 33% of Patients

Physicians report that medication access impacts initial therapy choice for some patients and may require changes to preferred treatment plan ROCHESTER,...

OPRX : 8.66 (+3.34%)
1 in 3 Surveyed Physicians Say They Would Make a Different Treatment Choice If Medication Access Was Not a Factor

1 in 4 say they’ve had to change a treatment plan due to medication access issues, highlighting how access barriers can impact patient care ROCHESTER,...

OPRX : 8.66 (+3.34%)
How to Find New Stocks for Your Portfolio

I like to read articles by people who aren't just bullish -- they've bought shares.

OPRX : 8.66 (+3.34%)
SI : 1.2500 (+0.81%)
LC : 10.96 (+0.83%)
VIR : 6.12 (-2.70%)
NARI : 79.97 (+0.05%)
Financial Times Ranks OptimizeRx Amongst Americas’ Fastest-Growing Companies for the Third Consecutive Year

OptimizeRx grew 2021 revenue by 42% year-over-year, spotlighting the rapid growth from the convergence of technology and healthcare...

OPRX : 8.66 (+3.34%)
OptimizeRx Acquires EvinceMed, a Specialty Drug Prescription Initiation Platform

OptimizeRx expands reach of its point-of-care solutions to simplify the prescribing process of specialty medications for healthcare providers, and to...

OPRX : 8.66 (+3.34%)
OptimizeRx to Participate In-Person at 34th Annual ROTH Conference, March 13-15, 2022

ROCHESTER, Mich., March 07, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology...

OPRX : 8.66 (+3.34%)
OptimizeRx Corporation (OPRX) Q4 2021 Earnings Call Transcript

OPRX earnings call for the period ending December 31, 2021.

OPRX : 8.66 (+3.34%)
OptimizeRx Reports Fourth Quarter and Full Year 2021 Financial Results, Revenue Increased 42%, Demand from Large Pharma Gains Momentum

Fourth quarter revenue Up 24% to $20.3 million, gross profit margin of 61%Introduction of key performance indicators (KPIs) representing “land and expand”...

OPRX : 8.66 (+3.34%)
OptimizeRx’s Mike Rousselle Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars

ROCHESTER, Mich., Feb. 01, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology...

OPRX : 8.66 (+3.34%)

Business Summary

Silvercrest Asset Management Group Inc. provides financial advisory and related family office services to high net worth individuals and institutional investors primarily in the United States. Silvercrest Asset Management Group Inc. is headquartered in New York.

See More

Key Turning Points

3rd Resistance Point 15.66
2nd Resistance Point 15.44
1st Resistance Point 15.23
Last Price 15.03
1st Support Level 14.80
2nd Support Level 14.58
3rd Support Level 14.37

See More

52-Week High 19.20
Fibonacci 61.8% 17.27
Fibonacci 50% 16.67
Fibonacci 38.2% 16.08
Last Price 15.03
52-Week Low 14.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.